Clinical Trial

Real World Adherence of PCSK9 Targeted Therapy

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 20, 2026 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Retrospective observational cohort study to compare medication adherence at 12 months between patients in Japan with dyslipidemia and/or hypercholesterolemia (familial and non-familial hypercholesterolemia) who newly initiate inclisiran versus those who newly initiate evolocumab.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-09.
Trial Details
NCT Number NCT07468500
Lead Sponsor Novartis Pharmaceuticals
Conditions Dyslipidemia, Hypercholesterolemia
Enrollment 3,600 participants
Start Date 2026-03-30
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-20